Arcutis Biotherapeutics Inc (ARQT) Inventory Turnover Ratio, from second quarter 2026 to second quarter 2025, current and historic results, rankings and more, Quarterly Fundamentals - CSIMarket
CSIMarket Company Name, Ticker, Competitors, else..
 
Arcutis Biotherapeutics Inc   (NASDAQ: ARQT)
 

Arcutis Biotherapeutics Inc Inventory Turnover Ratio (COS)

Cost of Sales Formula, Quarterly Results, Trends, Rankings, Statistics

Due to inventory build up in the second quarter 2026, Arcutis Biotherapeutics Inc 's inventory turnover ratio sequentially decreased to 1.35 in the second quarter 2026, otherwise the ratio remained above the average, as ARQT's markets remain strong.Arcutis Biotherapeutics Inc 's average inventory processing period in the Jun 30 2026 quarter, has increased to 270 days, from 240 days, in the Mar 31 2026 quarter.

Within Healthcare sector 279 other companies have achieved higher inventory turnover ratio. While Inventory turnover ratio total ranking has improved so far during the II Quarter 2026, to 1717, from total ranking in the first quarter 2026 at 1801.

ARQT Inventory Turnover Ratio using Sales Formula
What is Inventory Turnover Ratio?
What is Arcutis Biotherapeutics Inc Market Share?

What is Inventory Turnover Ratio?



Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

ARQT Inventory Turnover Ratio (Jun 30 2026)
II. Quarter		 (Mar 31 2026)
I. Quarter		 (Dec 31 2025)
IV. Quarter		 (Sep 30 2025)
III. Quarter		 (Jun 30 2025)
II. Quarter
Y / Y Inventory Growth 138.17 % 125.06 % 55.82 % 59.96 % 17.61 %
Y / Y Cost of Sales Growth 46.01 % 10.8 % 69.27 % 57.82 % 116.28 %
Inventory Turnover Ratio (TTM) 1.35 1.52 1.88 1.83 1.87
ARQT's Total Ranking # 1717 # 1801 # 1661 # 1644 # 1720
Average inventory processing period 269 239 194 200 195
Seq. Inventory Growth 3.98 % 65.2 % 0.96 % 37.34 % -1.75 %
Seq. Cost of Sales Growth 11.8 % -16.29 % 34.58 % 15.92 % -15.15 %




Inventory Turnover Ratio Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry # 76
Healthcare Sector # 280
Overall Market # 1717

Inventory Turnover Ratio Statistics
High Average Low
1.88 1.15 0.3
(Dec 31 2025)   (Jun 30 2023)



ARQT Company Profile >> Back to ARQT Efficiency Comparisons >> Compare ARQT Inventory Turnover Ratio to its Competitors

Financial Statements
Arcutis Biotherapeutics Inc 's Inventories $ 39 Millions Visit ARQT's Balance sheet
Arcutis Biotherapeutics Inc 's Cost of Revenues TTM $ 41 Millions Visit ARQT's Income Statement
What are ARQT's Sales? Visit ARQT's Sales by Segment

Other Inventory Turnover Ratios
Arcutis Biotherapeutics Inc 's Inventory to Sales Ratio
U.S. Durable Goods Inventory to Shipment Ratio By Product
Major Pharmaceutical Preparations Industry Inventory Turnover Trends and Statistics
Healthcare Sector Inventory Turnover Statistics
Inventory Turnover Trends for overall market
ARQT's Inventory Turnover Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Inventory Turnover
Lowest Ranking Inventory Turnover
Inventory Turnover for ARQT's Competitors
Inventory Turnover Ratio for ARQT's Suppliers
Inventory Turnover Ratio for ARQT's Customers

You may also want to know
ARQT's Sales Growth Rates ARQT's Pe Price to earnings ratio ARQT's Receivables Turnover Ratio ARQT's Stock Quote
ARQT's Net Income Growth Rates ARQT's Ps Price to Sales ratio ARQT's Sales per Employee ARQT's Asset Turnover Ratio
ARQT's Net Margin ARQT's Pb Price to Book ratio ARQT's Financial Strength Ratios ARQT's Dividend Payout Ratio



Companies with similar Inventory Turnover Ratio for the quarter ending Jun 30 2026, within Healthcare Sector Inventory Turnover Ratio Cost of revenues at quarter ending Jun 30 2026 Inventories at quarter ending Jun 30 2026
Logicmark Inc  2.83 $ 3.881  Millions$ 1  Millions
Iovance Biotherapeutics inc   2.81 $ 152.872  Millions$ 54  Millions
Livanova Plc  2.79 $ 468.065  Millions$ 168  Millions
Merck and Co Inc   2.79 $ 17,996.000  Millions$ 6,447  Millions
Inspiremd Inc   2.78 $ 8.847  Millions$ 3  Millions
Dentsply Sirona Inc   2.77 $ 1,839.000  Millions$ 663  Millions
Ani Pharmaceuticals Inc  2.69 $ 387.398  Millions$ 144  Millions
International Stem Cell Corporation  2.61 $ 4.285  Millions$ 2  Millions
Biomerica Inc   2.59 $ 4.091  Millions$ 2  Millions
Evofem Biosciences Inc   2.58 $ 4.418  Millions$ 2  Millions
Nephros Inc   2.54 $ 8.991  Millions$ 4  Millions
Illumina Inc   2.52 $ 1,510.000  Millions$ 599  Millions
IMPACT BIOMEDICAL INC.  2.46 $ 0.414  Millions$ 0  Millions
Quidelortho Corp  2.45 $ 1,481.500  Millions$ 605  Millions
Perrigo Company Plc  2.43 $ 2,775.900  Millions$ 1,140  Millions
Pro dex Inc   2.43 $ 53.213  Millions$ 22  Millions
Angiodynamics Inc   2.43 $ 142.834  Millions$ 59  Millions
Cytosorbents Corporation  2.43 $ 10.584  Millions$ 4  Millions
Journey Medical Corp  2.42 $ 23.556  Millions$ 10  Millions
Aquestive Therapeutics Inc   2.42 $ 17.828  Millions$ 7  Millions
Viatris Inc   2.41 $ 9,604.200  Millions$ 3,993  Millions
Electrocore Inc   2.40 $ 4.346  Millions$ 2  Millions
Cannapharmarx Inc   2.37 $ 2.483  Millions$ 1  Millions
Aurinia Pharmaceuticals Inc   2.34 $ 30.036  Millions$ 13  Millions
Fortress Biotech Inc   2.34 $ 22.768  Millions$ 10  Millions
Scientific Industries Inc   2.33 $ 4.057  Millions$ 2  Millions
Resmed Inc   2.33 $ 2,176.428  Millions$ 933  Millions
Insight Molecular Diagnostics Inc   2.31 $ 0.868  Millions$ 0  Millions
Tela Bio Inc   2.30 $ 26.348  Millions$ 11  Millions
Sanara Medtech Inc   2.29 $ 7.981  Millions$ 3  Millions

Date modified: 2026-09-09T00:21:01+00:00




Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.